Latest YTEN reports update at 2024-05-15: 2024-Q12023-Q42023-Q1
Yield10 Bioscience logo
Yield10 Bioscience YTEN
$ 5.87 15.32%

Yield10 Bioscience Financial Ratios 2011-2024 | YTEN

Annual Financial Ratios Yield10 Bioscience

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.2 -1.0 -1.6 -4.9 -0.2 -1.1 -0.7 -1.4 -0.9 -0.9 -1.6 14.3 -2.1

P/S

50.3 29.4 28.1 62.1 2.9 18.0 6.7 8.9 8.3 9.0 9.1 1.2 57.5

EPS

-1.8 -2.8 -2.3 -4.3 -35.5 -0.9 -3.3 -2.7 -0.9 -2.9 -5.3 0.1 -1.2

EV (Enterprise Value)

8.34 M 14.5 M 16.3 M 51.2 M 17.8 M 9.49 M -4.79 M 7.36 M 13.3 M 9.49 M 47.6 M 43.6 M 104 M

EBITDA per Share

-1.78 -2.68 -2.42 -2.83 -23 -36.6 -110 -140 -376 -1.03 K -2.06 K 344 -2.87 K

EV/EBITDA

-1.2 -5.2 0.4 -0.8 0.9 -0.3 -0.4 -0.2 -1.4 7.6 -1.6

PEG

0.01 0.02 0.03 -0.06 -0.05 -0.02 0.03 -0.02 -0.01 -0.02 0.0 0.13 -0.15

P/B

-1.2 3.0 1.1 5.2 -0.6 1.8 0.5 1.6 1.7 1.3 2.4 1.1 2.1

P/CF

-0.3 -1.2 -1.9 -5.7 -0.3 -1.1 -0.8 -0.7 -1.0 -1.0 -1.8 -1.6 -2.5

ROE %

582.16 -308.32 -68.83 -107.07 317.16 -160.51 -69.59 -119.39 -181.77 -157.13 -149.55 7.67 -98.28

ROA %

-369.98 -167.79 -54.03 -70.28 -77.50 -111.91 -55.66 -70.75 -138.58 -127.66 -114.09 6.78 -46.78

ROCE %

580.63 -305.70 -72.96 -75.61 -59.24 -139.50 -63.99 -128.26 -180.17 -141.61 -148.48 7.58 -51.30

Current Ratio

0.6 2.2 4.7 5.7 5.3 4.1 6.3 2.8 3.8 5.2 4.1 8.2 10.9

DSO

- 66.5 74.3 51.6 41.7 105.0 46.0 59.2 75.1 75.2 83.6 11.1 194.9

DIO

- - - - - - - - 209.6 144.3 491.4 820.1 -

DPO

- - - - - - - - 66.4 82.0 69.8 315.6 7.6

Operating Cycle

- 66.5 74.3 - - - - - 284.7 219.5 575.0 831.2 194.9

Cash Conversion Cycle

- 66.5 74.3 - - - - - 218.4 137.5 505.1 515.6 187.3

All numbers in USD currency

Quarterly Financial Ratios Yield10 Bioscience

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-4.77 - -0.41 -0.64 -18.16 - -0.71 -0.7 -0.68 - -0.49 -0.64 -0.6 - -0.87 -0.92 -2.12 - -6.33 -5.99 -8.61 - -0.26 -0.24 -0.92 - -0.59 -0.96 -0.74 - 1.44 -1.15 -0.24 -0.22 -0.22 -0.26 -0.26 -0.31 -0.84 -0.21 -0.23 -0.24 -0.21 -0.23 -0.2 -0.28 -0.23 -0.23 0.84 -0.28 -0.28 -0.33 -0.36

EBITDA per Share

-4.58 - - - -17.9 - -0.67 -0.68 -0.67 - -0.6 -0.61 -0.58 - -0.83 -1.04 -1.54 - -5.91 -5.76 -8.51 - -0.25 -0.23 -0.23 - -0.53 -0.91 -0.71 - -0.77 -0.81 -0.13 -0.22 -0.11 -0.26 -0.26 -0.26 -0.67 -0.18 -0.21 -0.23 -0.17 -0.2 -0.19 -0.28 -0.2 -0.21 0.86 -0.28 -0.25 -0.31 -0.34

ROE %

-2453.49 -1908.48 -1956.80 -1054.62 -461.05 -107.06 -120.03 -84.68 -66.27 -39.17 -61.92 -71.69 -75.42 -79.35 -30.83 40.43 105.07 149.65 103.35 8.53 -79.27 -128.52 -143.52 -112.22 -90.42 -50.69 12.49 90.67 60.66 -89.06 -134.47 -242.54 -238.95 -181.77 -169.61 -166.72 -158.60 -157.13 -166.16 -159.71 -159.79 -149.56 -127.37 -108.18 -86.41 7.67 3.44 -4.43 -12.93 -98.28 -24.23 -25.29 -24.43

ROA %

-244.31 -195.28 -226.23 -195.52 -156.93 -74.55 -85.00 -64.50 -52.64 -32.01 -46.93 -51.41 -51.52 -52.09 -63.94 -60.87 -59.69 -36.57 -56.92 -65.42 -72.69 -56.50 -68.50 -60.14 -57.83 -40.54 -3.10 46.33 32.73 -52.77 -87.40 -159.06 -164.85 -138.58 -130.98 -130.87 -126.61 -127.66 -132.90 -125.90 -124.05 -114.10 -99.62 -86.97 -72.41 6.78 12.99 15.93 18.74 -46.78 -11.53 -12.04 -11.63

ROCE %

-2440.34 -1901.80 -1950.14 -1053.84 -462.59 -106.93 -123.65 -92.03 -73.63 -42.83 -65.84 -72.14 -79.50 -73.43 -24.52 47.41 116.29 151.31 104.35 8.47 -80.66 -130.29 -144.97 -112.69 -90.10 -50.02 -90.91 -117.11 -136.41 -135.89 -181.31 -164.27 -171.93 -161.05 -146.53 -158.38 -147.31 -142.41 -150.58 -146.74 -146.79 -139.94 -120.99 -105.49 -86.27 7.61 3.35 -4.57 -13.11 -98.47 -24.27 -25.35 -24.48

Current Ratio

0.6 0.6 1.1 1.1 1.3 2.2 2.8 3.6 4.4 4.7 5.2 5.3 6.2 2.9 2.9 2.9 2.9 0.8 0.8 0.8 0.8 1.8 1.8 1.8 1.8 5.0 5.0 5.0 5.0 2.5 2.5 2.5 2.5 4.2 4.2 4.2 4.2 5.3 5.3 5.3 5.3 4.2 4.2 4.2 4.2 8.7 8.7 8.7 8.7 1.9 1.9 1.9 1.9

DSO

- - - - - - 29.6 70.4 88.2 - 49.6 30.1 29.1 - 38.5 35.5 40.3 - 29.3 20.7 61.1 - 112.9 30.1 112.5 - 22.1 16.8 16.9 - 12.7 32.0 88.3 43.8 66.4 29.2 20.0 4.8 6.5 5.9 77.6 122.0 144.6 53.3 43.1 54.8 113.6 83.0 1.1 30.4 28.4 69.8 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - 29.6 70.4 88.2 - 49.6 30.1 29.1 - 38.5 35.5 40.3 - 29.3 20.7 61.1 - 112.9 30.1 112.5 - 22.1 16.8 16.9 - 12.7 32.0 88.3 43.8 66.4 29.2 20.0 4.8 6.5 5.9 77.6 122.0 144.6 53.3 43.1 54.8 113.6 83.0 1.1 30.4 28.4 69.8 -

Cash Conversion Cycle

- - - - - - 29.6 70.4 88.2 - 49.6 30.1 29.1 - 38.5 35.5 40.3 - 29.3 20.7 61.1 - 112.9 30.1 112.5 - 22.1 16.8 16.9 - 12.7 32.0 88.3 43.8 66.4 29.2 20.0 4.8 6.5 5.9 77.6 122.0 144.6 53.3 43.1 54.8 113.6 83.0 1.1 30.4 28.4 69.8 -

All numbers in USD currency